Key Insights

Highlights

Treatment Research

3 treatments under study, led by Mr Imaging

Research Leaders

5 sponsors active, led by Stanford University

Related Conditions

Often studied with 20 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

75.0%

3 terminated out of 4 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

0

Data Visualizations

Phase Distribution

Trial Status

Terminated3
Withdrawn1

Clinical Trials (4)

Showing 4 of 4 trials
NCT00767936Terminated

Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocellular Carcinoma

NCT01071434Terminated

Feasibility of Using Real-time Cine-MRI for Treating Moving & Deforming Tumors

NCT01031056Withdrawn

Collection of Biospecimen & Clinical Information in Patients w/ Gastrointestinal Cancers

NCT00768001Terminated

Genetic Analysis of Liver Cancer

Showing all 4 trials

Research Network

Common Treatments

  • Mr Imaging1
  • Blood Draw1
  • Frozen Tumor Specimens1

Active Sponsors

  • Stanford University3
  • Samuel So1
  • GI Cancer Research Gift Fund1
  • Caring for Carcinoid Foundation1
  • The American Association of Physicists in Medicine1

Top Investigators

Related Conditions

  • Hepatobiliary Cancers4
  • Liver Cancer3
  • Hepatitis B2
  • Hepatitis C2
  • Pancreatic Cancer2

Activity Timeline